The cost of newly diagnosed breast cancer in Lithuania, 2011
Materials and methods: The retrospective incidence-based top-down direct cost analysis was used. From January 1 to December 31, 2011 incident cases of BC (N = 1142) registered by the National Health Insurance Fund, the stage determined by Lithuanian Cancer Registry were included in the study.
Results: The total average direct cost of BC amounted per patient was2580 (95% CI 2444–2752) EUR in 2011. The main cost driver per BCpatients was the inpatient hospital stay, respectively 1655 (95% CI 1478–2334) EUR. The average outpatient cost for one BC patient was 564 (95% CI 547–898) EUR. The dominant proportion of inpatient expenditureswas assigned to BC surgery and chemotherapy treatment. The BC direct medical cost increased according to the diagnosed stage of diseases from2409 (95% CI 2196–2621) EUR in stage 1 to3688 (95% CI 2703–4672) EUR in stage 4. The direct medical cost was inversely proportional to age.
Conclusions: The direct BC medical cost estimates provided by this analysis can be used to determine priorities for the future research on BC treatment interventions.
Ivanauskienė, R.; Domeikienė, A.; Kregždytė, R.; Milašauskienė, Ž.; Padaiga, Ž. The cost of newly diagnosed breast cancer in Lithuania, 2011. Medicina 2015, 51, 63-68.
Ivanauskienė R, Domeikienė A, Kregždytė R, Milašauskienė Ž, Padaiga Ž. The cost of newly diagnosed breast cancer in Lithuania, 2011. Medicina. 2015; 51(1):63-68.Chicago/Turabian Style
Ivanauskienė, Rugilė; Domeikienė, Auksė; Kregždytė, Rima; Milašauskienė, Žemyna; Padaiga, Žilvinas. 2015. "The cost of newly diagnosed breast cancer in Lithuania, 2011." Medicina 51, no. 1: 63-68.